Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30

$1.66−0.03 (-1.78%)

Close on Nov 12, 2026Market cap $590.23MP/E –Yield –

Evotec profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2022 it was -23.4%, against 34.9% the year before.

Period	Period end	Value	Change (pts)
FY2022	Dec 31, 2022	-23.4%	−58.2
FY2021	Dec 31, 2021	34.9%	+33.6
FY2020	Dec 31, 2020	1.3%	−7.3
FY2019	Dec 31, 2019	8.5%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVO.

Revenue growth-1.1% · median 15.8%

Operating margin-7.1% · median -64.0%

Advertisement
300 × 250

See a number that looks wrong?